By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Panelists agree that UiPath's Coding Agents platform is a necessary defensive move but may not drive significant growth. The company faces risks from commoditization, margin pressure, and competition from Microsoft and others.
Risk: Commoditization of 'agentic' workflows and competition from Microsoft and others bundling automation tools.
Opportunity: Potential to broaden deal sizes and cross-sell within existing customers as automation workloads shift to code-based agents.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
UiPath Inc. (NYSE:PATH) is one of the cheap robotics stocks to buy right now. On May 12, UiPath Inc. (NYSE:PATH) announced plans to make it easier for enterprises to deploy coding agents with built-in orchestration and governance capabilities.
UiPath for Coding Agents is the company’s new platform designed to make it easier for organizations to use coding agents, including Code and OpenAI Codex, to build, test, deploy, and operate automations through natural language conversations. The platform comes with capabilities for connecting coding agents to CI/CD infrastructure, testing frameworks, and governance controls.
The new platform is currently available to enterprise customers, enabling business analytics process owners and domain experts to create automations through conversations. Its unveiling comes on the heels of the company releasing several agentic AI tools through its Automation Suite platform, as it seeks to enhance its automation solutions across various sectors. UiPath’s Purchase-to-Pay solution streamlines procurements and accounts payable operations, reducing manual processing in purchase-to-pay workflows.
UiPath Inc. (NYSE:PATH) specializes in Robotic Process Automation (RPA), which means it builds software robots that act as digital workers rather than physical hardware. These software robots are designed to mimic human-computer interactions to automate repetitive, rule-based, and time-consuming tasks.
While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Sin Stocks to Buy Now and 8 Best CBD Stocks to Buy Right Now.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"UiPath’s transition to agentic orchestration is a desperate attempt to defend its platform moat against encroachment from hyperscalers like Microsoft and Salesforce."
UiPath’s pivot toward agentic AI and natural language coding is a defensive necessity, not necessarily a growth catalyst. By integrating coding agents, PATH is attempting to lower the barrier to entry for its RPA platform, which has historically suffered from high implementation friction and long sales cycles. However, the market is rapidly commoditizing 'agentic' workflows; Microsoft’s Power Automate and Salesforce’s Agentforce have deeper hooks into the enterprise stack. PATH’s valuation looks attractive at ~3x forward revenue, but this reflects a market pricing in structural churn as low-code tools cannibalize traditional, complex RPA workflows. The company is fighting to remain the 'orchestration layer' in a world where AI agents increasingly perform the work themselves.
The strongest bear case is that UiPath is being squeezed into a niche utility role by hyperscalers who provide free automation tools as part of their existing cloud and productivity suites.
"Feature announcements without evidence of accelerating customer adoption or margin expansion are insufficient to justify PATH's valuation when RPA incumbents face structural headwinds from AI commoditization."
UiPath's coding agent platform is tactically sound—orchestration + governance address real enterprise friction—but the announcement itself is feature parity, not differentiation. The market already prices in agentic AI adoption across RPA vendors (Automation Anywhere, Blue Prism). PATH trades at ~3.2x sales with negative free cash flow; the article's 'cheap robotics stock' framing ignores that valuation compression reflects persistent RPA margin pressure and customer concentration risk. The real question: does this feature unlock net-new TAM or just defend existing seats against better-capitalized competitors (Microsoft, ServiceTitan)?
If enterprises genuinely adopt natural-language-driven automation at scale, PATH's developer-friendly positioning and existing install base could drive meaningful attach rates and expand ARPU faster than the market assumes, justifying current multiples.
"The article's own pivot away from PATH reveals the announcement is incremental marketing rather than a catalyst with clear financial impact."
UiPath's new Coding Agents platform integrates orchestration and governance for tools like OpenAI Codex, letting non-coders build automations via natural language while linking to CI/CD pipelines. This fits the shift toward agentic AI on top of its RPA core, yet the article immediately pivots to touting a different undervalued AI name with lower downside, undercutting its own PATH endorsement. No metrics on expected revenue lift, adoption rates, or competitive differentiation appear. PATH still faces margin pressure and slower enterprise deal velocity typical in RPA after the 2021-22 hype cycle. Execution risk on turning announcements into billings remains unaddressed.
Enterprise customers already using Automation Suite could adopt the new agents quickly, driving measurable upsell in FY2026 if governance features reduce IT friction that has historically slowed RPA rollouts.
"UiPath's new coding agents platform could unlock enterprise expansion, but the real test is whether ARR growth and margin expansion can materialize in a maturing RPA market amid stiff competition."
UiPath's Coding Agents platform signals a step beyond pure RPA toward AI-assisted automation with governance, which could broaden deal sizes and cross-sell within existing customers as automation workloads shift to code-based agents. If it meaningfully lowers development friction, reduces time-to-automation, and ties into CI/CD and governance, ARR expansion and higher take-rates could follow. Yet the core growth story remains fragile: the RPA market is maturing, enterprise buyers are scrutinizing ROI, and Microsoft and others are bundling automation tools at attractive prices. Without clear evidence of accelerating revenue growth or margin improvement, the upbeat framing risks overestimating near-term upside.
However, this looks like incremental product enhancement rather than a transformative shift; governance features may slow deployments, not accelerate them, and giants like MSFT could bundle automation at lower cost, undercutting UiPath's pricing power.
"UiPath's true defense is the high switching cost of its legacy system integrations, not its new agentic features."
Claude is right about feature parity, but everyone is missing the 'vendor lock-in' trap. Enterprises aren't choosing between Microsoft and UiPath based on feature sets; they are choosing based on the cost of migrating legacy SAP/Oracle integrations. UiPath’s moat isn't the agent—it’s the deep, brittle connectivity to on-prem legacy systems that Microsoft’s cloud-native agents struggle to touch. The risk isn't just commoditization; it's the high technical debt of their own install base.
"Legacy lock-in delays churn but doesn't prevent it; it's a slow fade, not a moat."
Gemini's legacy lock-in thesis is compelling but overstates UiPath's defensibility. SAP/Oracle integrations are painful—true—but they're also *why* enterprises are actively ripping out RPA in favor of native cloud ERP modules and API-first tools. UiPath's moat isn't the connectivity; it's the switching cost of retraining 10,000 citizen developers. That's real, but it erodes as those developers retire or upskill to Python. The vendor lock-in cuts both ways: it keeps some customers, but it also signals to new buyers that UiPath is legacy infrastructure.
"Compliance-certified RPA scripts create a 3-5 year migration lag that Claude's switching-cost erosion argument underweights."
Claude's erosion timeline via developer upskilling ignores how regulated industries embed RPA scripts behind multi-year compliance certifications. Migrating those validated workflows to native cloud ERP or API tools triggers full re-audits and sign-offs that most firms defer for 3-5 years. This extends PATH's maintenance revenue tail on the installed base but simultaneously reinforces the perception of legacy infrastructure, further deterring net-new logos against Microsoft bundling.
"Legacy connectivity isn't UiPath's sole moat; margin/maintenance costs and compliance headwinds risk capping growth, especially if cloud bundling erodes cross-sell upside."
Gemini's emphasis on legacy connectivity as UiPath's moat feels overdone. The bigger near-term risk is margin compression from maintaining a large on-prem/install base and the compliance overhead of multi-year certifications, which can cap expansion and keep support costs high. If Microsoft and others bundle automation more deeply, PATH must demonstrate clear governance-driven upsell, not just lock-in. Without that, the valuation assumes growth that may never materialize.
Panelists agree that UiPath's Coding Agents platform is a necessary defensive move but may not drive significant growth. The company faces risks from commoditization, margin pressure, and competition from Microsoft and others.
Potential to broaden deal sizes and cross-sell within existing customers as automation workloads shift to code-based agents.
Commoditization of 'agentic' workflows and competition from Microsoft and others bundling automation tools.